Report cover image

Global Very-small-aperture Terminal (VSAT) Market Growth (Status and Outlook) 2025-2031

Published Aug 11, 2025
Length 150 Pages
SKU # LPI20294640

Description

According to this study, the global Recombinant Protein Customization Service market size will reach US$ 11713 million by 2031.

Recombinant protein customization service is aimed at specific proteins. Contract research/production organizations provide one-stop customized services including gene synthesis, expression vector construction, expression system screening (such as E. coli, yeast, insect or mammalian cells), purification process development, modification (such as labeling, glycosylation, label removal, etc.) and quality analysis based on the sequence or functional requirements provided by customers. This service is widely used in antibody drug development, vaccine research, structural biology, protein-protein interaction research, enzyme engineering, diagnostic reagents and other fields, and is one of the key technical supports for basic research and industrialization of biomedicine.

United States market for Recombinant Protein Customization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Recombinant Protein Customization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Recombinant Protein Customization Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Recombinant Protein Customization Service players cover ProteoGenix, Bio-Techne, VectorBuilder Inc, Biocompare, Biomatik, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Recombinant Protein Customization Service Industry Forecast” looks at past sales and reviews total world Recombinant Protein Customization Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Recombinant Protein Customization Service sales for 2025 through 2031. With Recombinant Protein Customization Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Protein Customization Service industry.

This Insight Report provides a comprehensive analysis of the global Recombinant Protein Customization Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Recombinant Protein Customization Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Recombinant Protein Customization Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Protein Customization Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Protein Customization Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Protein Customization Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Purity ≥ 85%
Purity ≥ 95%
Purity ≥ 98%
Others

Segmentation by Application:
Pharmaceutical Companies
Biological Laboratories
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
ProteoGenix
Bio-Techne
VectorBuilder Inc
Biocompare
Biomatik
Eurofins Discovery
ProMab
Thermo Fisher
RayBiotech
Akron Biotech
AGC Biologics
OriGene
Calixar
Hzymes Biotechnology
Mabioway
Genscript
Abace Biotechnology
Sino Biological
Detai Bioscience
ACROBiosystems
UA BIOSCIENCE
Cusabio

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

150 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Sodium Polyitaconate by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Sodium Polyitaconate by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.